New York Ventures Direct Fund

esd.ny.gov/venture-capital

Foreign Government Fund

Tech Verticals Preferences

Advanced Manufacturing, AgriTech, Artificial Intelligence, Biotechnology, Cleantech, Climate Tech, Consumer, Data Analysis, Deep Tech, Energy Tech, FinTech, Healthcare IT, Healthtech, Impact, Life Sciences, Medical Devices, SaaS

General Data

Established	2015
Current Active Portfolio Companies:	1

DESCRIPTION

New York Ventures, a division of Empire State Development, is an early-stage venture capital fund that invests in high growth start-up companies that are led by diverse entrepreneurial teams, across all regions of New York State. New York Ventures is actively deploying over $300 million of capital through equity programs for both direct and indirect investment.

CONTACT INFO

Expand / Collapse All

Main Address: New York, United States

Address	655 Third Ave, 3rd Fl
City	New York
State/Province	NY
Country	United States
Zip	10017

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Ms. Jennifer Tegan	Managing Director
Ms. Silvia Garcia-Codony	Assistant VP
Mr. Karan Mehta	Early Stage Investor	Octopus Ventures (Early Stage Investor)

Investment Data

Managed Capital

abCDe

Preferences

Type of Financing	Equity,Investments in Funds
Stage Preferences	Initial Revenues,R&D,Seed

SECTOR SEGMENTATION (By Number Of Companies)

Biomed

100%

	PORTFOLIO COMPANIES

Current Portfolio Companies (1)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

NeuroGenesis

Biomed

First Round

11/03/2022

N/A

$6.65m

Exits (2)

Company Name	Exit Type	Date Announced	Amount	Remarks
abC Defghij	Acquired	03/11/2021	abCDe
abC Defghij	Acquired	18/11/2025	abCDe	Part of WindRose's strategy of building a next-generation population health management platform.

Last Updated:	abCDe
IVC Number:	abCDe